ATE194330T1 - Dihydropyridine mit kurzer wirkung - Google Patents

Dihydropyridine mit kurzer wirkung

Info

Publication number
ATE194330T1
ATE194330T1 AT95900347T AT95900347T ATE194330T1 AT E194330 T1 ATE194330 T1 AT E194330T1 AT 95900347 T AT95900347 T AT 95900347T AT 95900347 T AT95900347 T AT 95900347T AT E194330 T1 ATE194330 T1 AT E194330T1
Authority
AT
Austria
Prior art keywords
hydrogen
pct
chloro
methyl
nitro
Prior art date
Application number
AT95900347T
Other languages
English (en)
Inventor
Kjell Hjalmar Andersson
Margareta Nordlander
Rolf Christer Westerlund
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Application granted granted Critical
Publication of ATE194330T1 publication Critical patent/ATE194330T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • C07D211/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pyridine Compounds (AREA)
AT95900347T 1993-11-05 1994-11-03 Dihydropyridine mit kurzer wirkung ATE194330T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9303657A SE9303657D0 (sv) 1993-11-05 1993-11-05 Short-acting dihydropyridines
PCT/SE1994/001031 WO1995012578A1 (en) 1993-11-05 1994-11-03 Short-acting dihydropyridines

Publications (1)

Publication Number Publication Date
ATE194330T1 true ATE194330T1 (de) 2000-07-15

Family

ID=20391655

Family Applications (1)

Application Number Title Priority Date Filing Date
AT95900347T ATE194330T1 (de) 1993-11-05 1994-11-03 Dihydropyridine mit kurzer wirkung

Country Status (36)

Country Link
US (1) US5856346A (de)
EP (1) EP0726894B1 (de)
JP (1) JP3712209B2 (de)
KR (1) KR100331663B1 (de)
CN (1) CN1049428C (de)
AT (1) ATE194330T1 (de)
AU (1) AU685532B2 (de)
BR (1) BR9407946A (de)
CA (1) CA2174969C (de)
CZ (1) CZ285691B6 (de)
DE (1) DE69425152T2 (de)
DK (1) DK0726894T3 (de)
EE (1) EE03230B1 (de)
EG (1) EG20539A (de)
ES (1) ES2150544T3 (de)
FI (1) FI110429B (de)
FR (1) FR12C0053I2 (de)
GR (1) GR3034469T3 (de)
HK (1) HK1013292A1 (de)
HU (1) HU215591B (de)
IL (1) IL111127A (de)
IS (1) IS1674B (de)
LU (1) LU92209I2 (de)
MY (1) MY111770A (de)
NO (1) NO305656B1 (de)
NZ (1) NZ275915A (de)
PL (1) PL185099B1 (de)
PT (1) PT726894E (de)
RU (1) RU2139278C1 (de)
SA (1) SA94150250B1 (de)
SE (1) SE9303657D0 (de)
SK (1) SK281467B6 (de)
TW (1) TW279859B (de)
UA (1) UA45959C2 (de)
WO (1) WO1995012578A1 (de)
ZA (1) ZA947570B (de)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9804002D0 (sv) * 1998-11-23 1998-11-23 Astra Ab New manufacturing process
WO2003059193A2 (en) * 2001-12-21 2003-07-24 Alcon, Inc. Use of nanoparticles as carriers for biocides in ophthalmic compositions
FR2922439B1 (fr) * 2007-10-18 2010-12-10 Hill Rom Ind Sa Procede de gonflage alterne d'un dispositif de support a cellules gonflables et dispositif pour sa mise en oeuvre
SI2320740T1 (sl) 2008-08-01 2014-08-29 The Medicines Company Farmacevtski sestavki clevidipina in postopki za izdelavo nizke koncentracije neäśistoäś le-teh
PL2482658T3 (pl) * 2009-09-30 2015-10-30 Microdose Therapeutx Inc Sposoby i kompozycje do leczenia objawu Raynauda
CN101780036B (zh) * 2010-03-30 2011-11-16 武汉武药科技有限公司 丁酸氯维地平脂微球注射液及其制备方法
CA2701087A1 (en) * 2010-04-12 2011-10-12 Alphora Research Inc. Preparation of clevidipine butyrate ring the same
EP3020704A3 (de) 2010-05-07 2016-11-09 Laboratorios Lesvi, S.L. Kristalline polymorphen des clevidipins butyrate
US8455655B2 (en) 2010-05-07 2013-06-04 Laboratorios Lesvi, S.L. Preparation of dihydropyridines
EA022849B1 (ru) 2010-10-12 2016-03-31 Дзе Медсинз Компани Эмульсионные композиции клевидипина, содержащие противомикробные агенты
US8658676B2 (en) 2010-10-12 2014-02-25 The Medicines Company Clevidipine emulsion formulations containing antimicrobial agents
BR112013025368A8 (pt) * 2011-04-01 2018-06-12 The Medicines Co Medicamento, método para preparar um medicamento útil para reduzir danos por derrame em um sujeito com derrame, método para preparar um medicamento útil para reduzir a pressão sanguínea e reduzir danos por derrame em um sujeito com derrame
AU2012303683B2 (en) 2011-08-26 2016-09-08 Wockhardt Limited Methods for treating cardiovascular disorders
CN103420899B (zh) * 2012-05-25 2016-01-27 四川科伦药物研究有限公司 一种丁酸氯维地平的纯化方法
AU2013334081B2 (en) 2012-10-26 2017-05-18 Chiesi Farmaceutici S.P.A. Methods for controlling blood pressure and reducing dyspnea in heart failure
CN103073485B (zh) * 2013-01-17 2015-09-02 北京嘉林药业股份有限公司 一种丁酸氯维地平的制备方法
CN103086956B (zh) * 2013-01-17 2015-11-04 北京嘉林药业股份有限公司 一种丁酸氯维地平中间体的纯化方法
RU2759673C2 (ru) 2014-05-19 2021-11-16 КЬЕЗИ ФАРМАЧЕУТИЧИ С.п.А. Наночастицы клевидипина и их фармацевтические композиции
CN105367487A (zh) * 2014-08-23 2016-03-02 南京海纳医药科技有限公司 一种丁酸氯维地平重要中间体新的合成方法
CN104370802A (zh) * 2014-09-24 2015-02-25 北京蓝丹医药科技有限公司 氯维地平衍生物及其制备方法
RS62130B1 (sr) 2015-05-20 2021-08-31 Boehringer Ingelheim Animal Health Usa Inc Antihelmintička depsipeptidna jedinjenja
RU2715556C2 (ru) 2015-12-28 2020-03-02 Мериал, Инк. Противогельминтные депсипептидные соединения
WO2018093920A1 (en) 2016-11-16 2018-05-24 Merial, Inc. Anthelmintic depsipeptide compounds
RU2755349C1 (ru) * 2021-02-16 2021-09-15 Федеральное государственное автономное образовательное учреждение высшего образования "Белгородский государственный национальный исследовательский университет" (НИУ "БелГУ") Применение бензил 6-({ 2-[(3,4-диметилфенил)амино]-2-оксоэтил} тио)-2-метил-4-(4-хлорфенил)-5-циано-1,4-дигидропиридин-3-карбоксилата в качестве гепатопротекторного средства

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2117571C3 (de) * 1971-04-10 1979-10-11 Bayer Ag, 5090 Leverkusen Unsymmetrische 1,4-Dihydropyridin-33-dicarbonsäureester, Verfahren zu ihrer Herstellung sowie ihre Verwendung als Arzneimittel
US4154839A (en) * 1975-11-05 1979-05-15 Bayer Aktiengesellschaft 2,6-Dimethyl-3-carboxymethoxy-4-(2-nitrophenyl)-5-carbisobutoxy-1,4-dihydropyridine
DE2847236A1 (de) * 1978-10-31 1980-05-14 Bayer Ag Neue dihydropyridine mit substituierten estergruppierungen, mehrer verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
KR940003492B1 (ko) * 1988-10-27 1994-04-23 주식회사 유한양행 1,4-디하이드로피리딘유도체 및 그의 제조방법
US5134139A (en) * 1989-08-31 1992-07-28 Tanabe Seiyaku Co., Ltd. 1,5-benzothiazepine derivatives and preparation thereof
JPH0641075A (ja) * 1990-09-01 1994-02-15 Kazuo Achinami 新規な１，４−ジヒドロピリジン化合物及びその製造方法

Also Published As

Publication number Publication date
RU2139278C1 (ru) 1999-10-10
IS1674B (is) 1997-12-31
HUT75316A (en) 1997-05-28
JPH09504542A (ja) 1997-05-06
SK281467B6 (sk) 2001-04-09
SA94150250B1 (ar) 2006-03-01
JP3712209B2 (ja) 2005-11-02
CZ285691B6 (cs) 1999-10-13
EG20539A (en) 1999-07-31
SE9303657D0 (sv) 1993-11-05
FR12C0053I1 (de) 2012-02-11
AU8119694A (en) 1995-05-23
HU9601187D0 (en) 1996-07-29
PL185099B1 (pl) 2003-02-28
HU215591B (hu) 1999-01-28
EE03230B1 (et) 1999-10-15
US5856346A (en) 1999-01-05
HK1013292A1 (en) 1999-08-20
CN1137269A (zh) 1996-12-04
NZ275915A (en) 1997-04-24
DE69425152D1 (de) 2000-08-10
MY111770A (en) 2000-12-30
AU685532B2 (en) 1998-01-22
SK55996A3 (en) 1996-12-04
KR100331663B1 (ko) 2002-09-26
WO1995012578A1 (en) 1995-05-11
FR12C0053I2 (fr) 2013-08-16
PT726894E (pt) 2000-10-31
IL111127A (en) 2000-11-21
DK0726894T3 (da) 2000-10-23
TW279859B (de) 1996-07-01
FI110429B (fi) 2003-01-31
EP0726894B1 (de) 2000-07-05
ZA947570B (en) 1995-05-29
EP0726894A1 (de) 1996-08-21
CA2174969A1 (en) 1995-05-11
BR9407946A (pt) 1996-11-26
CN1049428C (zh) 2000-02-16
NO305656B1 (no) 1999-07-05
FI961914A (fi) 1996-05-06
NO961776D0 (no) 1996-05-02
CA2174969C (en) 2005-05-17
CZ127396A3 (en) 1996-09-11
LU92209I2 (fr) 2013-08-23
IS4218A (is) 1995-05-06
FI961914A0 (fi) 1996-05-06
PL314128A1 (en) 1996-08-19
NO961776L (no) 1996-05-02
IL111127A0 (en) 1994-12-29
DE69425152T2 (de) 2001-03-22
UA45959C2 (uk) 2002-05-15
GR3034469T3 (en) 2000-12-29
ES2150544T3 (es) 2000-12-01

Similar Documents

Publication Publication Date Title
ATE194330T1 (de) Dihydropyridine mit kurzer wirkung
DE69221721D1 (de) Ethanolaminderivate mit anti-pollakiurawirkung
ATE88468T1 (de) Arylalkoxycumarine, verfahren zu ihrer herstellung und diese enthaltende therapeutische mittel.
IL108970A0 (en) Substituted (arylalkylaminobenzyl) aminopropionamide derivatives, their preparation and pharmaceutical compositions containing them
DK0689534T3 (da) Amidderivater som 5-HT1A-ligander
NO973242L (no) Anvendelse av 3,4-difenylkromaner til fremstilling av et farmasöytisk preparat for behandling eller profylakse av idiopatisk eller fysiologisk gynekomasti
ES2006165A6 (es) Procedimiento para la preparacion de derivados de 1,4-dihidropiridina y sus sales de adicion farmaceuticamente aceptables

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification